Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Director/PDMR Shareholding

25 Jun 2020 10:20

RNS Number : 0783R
Scapa Group PLC
25 June 2020
 

25 June 2020

LEI No. 213800QIPVTK5ES5UU36

 

SCAPA GROUP PLC

('the Company')

 

Director/PDMR Shareholding

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities ('PDMR')

 

Scapa Group plc (AIM: SCPA) announces that it was notified on 24 June 2020 that Mr Heejae Chae, Group Chief Executive of the Company, purchased 19,899 Ordinary shares in the Company on 24 June 2020 at a price of 100.0 pence per share. Mr Chae's beneficial holding in the Company following the purchase is as follows:

 

Director/Person CloselyAssociated

No. of Ordinary Shares held prior to Purchase

No. of Ordinary Shares Purchased

No. of Ordinary Shares held following Purchase

Percentage of Issued Share Capital following Purchase

Heejae Chae

1,124,324

19,899

1,144,223

0.61%

 

Mr Chae also has a beneficial interest in respect of 1,645,766 (1.06%) Ordinary Shares, under the Scapa Group plc 2015 Value Creation Plan and 152,613 Ordinary Shares (0.10%) under the Scapa Group plc 2011 Performance Share Plan. These shares have vested and will be released to Mr Chae upon exercise pursuant to the respective plan rules.

 

The notification below, made in accordance with the requirements of Article 19 of the Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Heejae Chae

 

2

Reason for the notification

 

a)

Position / status

Group Chief Executive

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Scapa Group plc

 

b)

LEI

 

213800QIPVTK5ES5UU36

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

 

a)

Description of financial instrument,

type of instrument

Ordinary Shares of 5p each

 

Identification Code

 

GB0007281198

b)

Nature of the transaction

Purchase of shares

 

c)

Price(s) and volume(s)

 

Purchase of 19,899 shares at 100p per share

d)

Aggregated information

- Aggregated volume

- Price

Volume: 19,899 ordinary shares of 5p each, purchase price of 100 pence per share

Aggregated: £19,899

 

e)

Date of the transaction

 

24 June 2020

f)

Place of the transaction

 

London Stock Exchange, AIM

 

For further information:

 

Scapa Group plc:

Wendy Baker

Company Secretary

+44 (0) 161 301 7400

Numis Securities Limited:

Mark Lander/ Freddie Barnfield / Duncan Monteith

(Joint Broker/Nominated Adviser)

+44 (0) 20 7260 1000

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUVAKRRWUNURR
Date   Source Headline
1st Mar 201710:22 amRNSAdditional Listing
23rd Feb 201711:03 amRNSHolding(s) in Company
16th Feb 20179:21 amRNSHolding(s) in Company
7th Feb 20174:16 pmRNSBlock listing Interim Review
3rd Feb 20173:53 pmRNSHolding(s) in Company
26th Jan 201710:10 amRNSDirector/PDMR Shareholding
25th Jan 20174:33 pmRNSBlock listing Interim Review
25th Jan 201711:49 amRNSHolding(s) in Company
23rd Jan 20179:18 amRNSDirector/PDMR Shareholding
9th Jan 20179:41 amRNSAdditional Listing
22nd Dec 20162:15 pmRNSAdditional Listing
15th Dec 20167:00 amRNSDirectorate Change
13th Dec 20161:29 pmRNSAdditional Listing
24th Nov 20164:30 pmRNSDirector/PDMR Shareholding
24th Nov 20164:20 pmRNSDirector/PDMR Shareholding
22nd Nov 20164:20 pmRNSAdditional Listing
22nd Nov 20167:00 amRNSHalf-year Report
12th Oct 20167:00 amRNSTrading Statement
27th Sep 20162:53 pmRNSDirector/PDMR Shareholding
21st Sep 20161:51 pmRNSAdditional Listing
6th Sep 201610:24 amRNSAdditional Listing
2nd Sep 201611:20 amRNSBlock listing Interim Review
31st Aug 20169:14 amRNSTotal Voting Rights
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
12th Aug 201611:24 amRNSBlock listing Interim Review
11th Aug 20161:30 pmRNSDirector/PDMR Shareholding
10th Aug 201610:08 amRNSDirector/PDMR Shareholding
19th Jul 20164:58 pmRNSAdditional Listing
19th Jul 20167:00 amRNSAGM Statement
11th Jul 20163:48 pmRNSDirector/PDMR Shareholding
5th Jul 20162:25 pmRNSHolding(s) in Company
1st Jul 20162:58 pmRNSDirector/PDMR Shareholding
1st Jun 20163:49 pmRNSAdditional Listing
1st Jun 20167:00 amRNSAppointment of Joint Broker
24th May 20167:00 amRNSAcquisition
24th May 20167:00 amRNSFinal Results
18th May 201610:01 amRNSAdditional Listing
11th May 201610:45 amRNSHolding(s) in Company
18th Apr 20167:00 amRNSDirectorate Change
14th Apr 20167:00 amRNSTrading Statement
2nd Mar 20169:06 amRNSBlocklisting Interim Review
8th Feb 20169:49 amRNSBlocklisting Interim Review
28th Jan 20167:00 amRNSDirectorate Change
31st Dec 20157:00 amRNSTotal Voting Rights
15th Dec 20159:57 amRNSHolding(s) in Company
14th Dec 20158:26 amRNSHolding(s) in Company
14th Dec 20158:21 amRNSDirector/PDMR Shareholding
8th Dec 201511:46 amRNSHolding(s) in Company
8th Dec 201511:42 amRNSHolding(s) in Company
1st Dec 201510:52 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.